Perfil de liberación de biomarcadores miocárdicos en pacientes con enfermedades hemato-oncológicas que reciben trasplante de progenitores hematopoyéticos
{"title":"Perfil de liberación de biomarcadores miocárdicos en pacientes con enfermedades hemato-oncológicas que reciben trasplante de progenitores hematopoyéticos","authors":"Soledad Murguía, Federico Pagnussat, A. Simeone, Mariela Lujambio, Mónica Delorenzi, Federico Acquistapace, Lucia Florio, Federico Ferrando Castagnetto","doi":"10.29277/cardio.38.1.2","DOIUrl":null,"url":null,"abstract":": BNP release after HSCT is frequent (32% of our patients), reaching a maximum at one month, regard-less of LVEF. The subgroup of patients who received antimetabolites had a greater early release of BNP.","PeriodicalId":191575,"journal":{"name":"Revista Uruguaya de Cardiología","volume":"66 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Uruguaya de Cardiología","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29277/cardio.38.1.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
: BNP release after HSCT is frequent (32% of our patients), reaching a maximum at one month, regard-less of LVEF. The subgroup of patients who received antimetabolites had a greater early release of BNP.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
